Refractory Lymphoma

specific

A lymphoma that does not respond to treatment.

81

Centers

157

Active Trials

$907K

Cancer Funding

Top Centers for Refractory Lymphoma(81)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
83.0
2
NCI Comprehensive
High-Volume Research Center
79.5
3
NCI Comprehensive
High-Volume Research Center
78.9
4
NCI Comprehensive
High-Volume Research Center
77.2
5
NCI Comprehensive
High-Volume Research Center
75.2
6
NCI Comprehensive
High-Volume Research Center
74.0
7
NCI Comprehensive
High-Volume Research Center
70.2
8
Active Research Program
68.1
9
Active Research Program
66.6
10
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
65.6
11
NCI Comprehensive
Active Research Program
65.3
12
NCI Comprehensive
Active Research Program
65.1
13
NCI Comprehensive
Active Research Program
64.8
14
Active Research Program
64.6
15
NCI Clinical
Active Research Program
64.4
16
Active Research Program
64.2
17
NCI Comprehensive
Active Research Program
64.1
18
NCI Comprehensive
Active Research Program
63.6
19
NCI Comprehensive
Active Research Program
62.4
20
NCI Comprehensive
Active Research Program
62.1
21
NCI Comprehensive
Active Research Program
61.4
22
NCI Comprehensive
Active Research Program
61.1
23
NCI Comprehensive
Active Research Program
58.7
24
NCI Clinical
Active Research Program
58.4
25
Active Research Program
58.4
26
Active Research Program
57.4
27
NCI Comprehensive
Active Research Program
57.2
28
NCI Comprehensive
Active Research Program
56.9
29
NCI Clinical
Active Research Program
56.2
30
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
55.7
3155.5
32
NCI Comprehensive
Active Research Program
55.2
33
NCI Comprehensive
Active Research Program
55.0
34
Active Research Program
54.0
35
NCI Comprehensive
Active Research Program
53.7
36
NCI Comprehensive
Active Research Program
53.2
37
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
53.0
38
Active Research Program
52.7
39
Active Research Program
51.8
4050.8
41
Active Research Program
47.6
42
NCI Comprehensive
Active Research Program
47.6
43
NCI Clinical
Active Research Program
47.6
44
Active Research Program
47.6
45
Active Research Program
47.6
46
Active Research Program
47.6
4747.6
48
Active Research Program
47.6
49
Active Research Program
47.6
50
NCI Comprehensive
Active Research Program
47.0
51
NCI Comprehensive
Active Research Program
46.5
52
NCI Comprehensive
Active Research Program
44.8
53
NCI Comprehensive
Active Research Program
44.3
54
NCI Comprehensive
Active Research Program
43.3
55
Active Research Program
42.6
56
NCI Comprehensive
Active Research Program
42.1
57
NCI Comprehensive
Active Research Program
41.8
58
NCI Comprehensive
Active Research Program
41.6
59
NCI Comprehensive
Active Research Program
41.3
60
NCI Comprehensive
Active Research Program
40.6
61
NCI Comprehensive
Active Research Program
39.6
62
NCI Basic_laboratory
Active Research Program
39.4
63
NCI Comprehensive
Active Research Program
38.4
64
NCI Comprehensive
Active Research Program
38.1
65
NCI Comprehensive
Active Research Program
37.6
66
NCI Comprehensive
Active Research Program
35.9
67
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
35.2
68
Contributing Research Center
34.2
69
Contributing Research Center
33.2
70
NCI Comprehensive
Contributing Research Center
32.9
71
NCI Comprehensive
Contributing Research Center
32.2
72
Contributing Research Center
31.9
73
BC CancerVancouver, BC
Contributing Research Center
31.9
74
Contributing Research Center
31.7
75
Contributing Research Center
31.5
76
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Contributing Research Center
31.0
77
NCI Comprehensive
Contributing Research Center
29.2
78
NCI Comprehensive
Contributing Research Center
29.2
79
Contributing Research Center
29.2
80
Contributing Research Center
29.2
81
Contributing Research Center
29.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →